| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 10/06/2011 | US20110245501 Substituted Tetracycline Compounds as Synergistic Antifungal Agents |
| 10/06/2011 | US20110245250 Potassium ion channel modulators & uses thereof |
| 10/06/2011 | US20110245243 Compounds and compositions as cathepsin s inhibitors |
| 10/06/2011 | US20110245226 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 10/05/2011 | EP2370406A1 High penetration compositions and their applications |
| 10/05/2011 | EP2370402A2 Compounds for treating proliferative disorders |
| 10/05/2011 | EP2370395A1 Process for preparing secondary amides by carbonylation of a corresponding tertiary amine |
| 10/05/2011 | EP2297118B1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives as lxr modulators |
| 10/05/2011 | EP1278758B1 Combretastatin A-1 phosphate and Combretastatin B-1 phosphate prodrugs |
| 10/05/2011 | CN102206196A Method for recovering morpholine from acidic waste water containing morpholine |
| 10/05/2011 | CN102206172A Substituted diaryl compound and preparation method and antiviral application thereof |
| 10/05/2011 | CN102206161A Diamine, polymer obtained from reaction with the presence of the diamine, liquid crystal aligning agent containing the polymer, liquid crystal alignment layer and liquid crystal display device |
| 10/05/2011 | CN101684083B Guanidinoalkanoylamino substituted tetracycline derivatives |
| 10/04/2011 | US8030501 Process for producing optically active 3-amino nitrogen-containing compounds |
| 10/04/2011 | CA2631854C Photochromic indeno-fused naphthopyrans |
| 09/29/2011 | WO2011119345A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 09/29/2011 | WO2011118818A1 Amidinoaneline derivative |
| 09/29/2011 | WO2011118672A1 Plasma kallikrein inhibitor |
| 09/29/2011 | US20110237604 Methods for preventing or treating cardiac arrhythmia |
| 09/29/2011 | US20110237592 Substituted amido phenoxybenzamides |
| 09/29/2011 | US20110237553 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 09/29/2011 | US20110233048 Photobase generator |
| 09/29/2011 | CA2792276A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 09/28/2011 | EP2368876A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 09/28/2011 | EP2368875A1 Photobase generator |
| 09/28/2011 | EP2367807A1 Process for the preparation of piperazine derivatives |
| 09/28/2011 | EP2367781A1 New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties |
| 09/28/2011 | EP2231586B1 Azomethine direct dyes or reduced precursors of azomethine direct dyes obtained from 2-alkylresorcinols, and hair dyeing process using these dyes or precursors |
| 09/28/2011 | CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 09/28/2011 | CN102199096A Method for synthesizing organic ionic compounds |
| 09/28/2011 | CN101747294B Method for purifying N-(2,6-xylyl)-2-(1-piperazinyl)acetamide |
| 09/28/2011 | CN101311171B Compound with dual restraining activities to acetyl cholinesterase and butyryl cholinesterase and use thereof |
| 09/27/2011 | US8026239 Cell differentiation inducer |
| 09/27/2011 | US8026231 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 09/22/2011 | WO2011113512A1 Morpholinylquinazolines |
| 09/22/2011 | WO2011025982A3 Tetracycline compounds |
| 09/22/2011 | US20110230662 Radiolabelled fluorobenzamide analogues, their synthesis and use in diagnostic imaging |
| 09/22/2011 | US20110230496 Novel process for preparing highly pure levocetirizine and salts thereof |
| 09/22/2011 | US20110230488 Hybrid-ionone and curcumin molecules as anticancer agents |
| 09/22/2011 | US20110230446 Cathepsin cysteine protease inhibitors |
| 09/22/2011 | US20110230428 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| 09/22/2011 | CA2793299A1 Morpholinylquinazolines |
| 09/21/2011 | EP2366686A2 Copper electroplating bath and method |
| 09/21/2011 | EP2365962A2 Aminoalcohol lipidoids and uses thereof |
| 09/21/2011 | EP1505963B9 Hepatitis c virus inhibitors |
| 09/21/2011 | EP1487428B1 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 09/21/2011 | EP1003728B1 2-(3-(4-(2-t-Butyl-6-trifluoromethylpyrimidin-4-yl)piperazin-1-yl)propylmercapto)pyrimidin-4-ol-fumarate |
| 09/21/2011 | CN102197028A Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders |
| 09/21/2011 | CN102191115A Morpholine derivatives as ashless TBN sources and lubricating oil compositions containing same |
| 09/21/2011 | CN102190633A Cetirizine derivatives, and composition and application thereof |
| 09/21/2011 | CN102190535A Method for synthesizing E-alpha-cyan-4-substituted cinnamate compounds |
| 09/20/2011 | US8022111 Piperazino sensitisers |
| 09/20/2011 | US8022074 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 09/20/2011 | CA2669311C Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| 09/20/2011 | CA2657106C Aminoindane derivative or salt thereof |
| 09/20/2011 | CA2476067C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 09/20/2011 | CA2471943C .beta.-amyloid protein production-secretion inhibitors |
| 09/20/2011 | CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 09/20/2011 | CA2439415C Cathepsin cysteine protease inhibitors |
| 09/20/2011 | CA2115828C Calcium receptor active molecules |
| 09/15/2011 | WO2011060363A3 Cyclohexyl urea modulators of d2 receptors and/or d3 receptors |
| 09/15/2011 | US20110224213 Use of Glutaric Acid Derivatives or the Pharmaceutically Acceptable Salts Thereof as Anti-Arrhythmic Agents |
| 09/15/2011 | US20110223213 Highly pure ranolazine or a pharmaceutically acceptable salt thereof |
| 09/15/2011 | US20110220843 Polymer film, ultraviolet absorber, merocyanine compound and process for preparing merocyanine compound |
| 09/14/2011 | EP2364977A1 Process for the enantiomeric enrichment of 3-methyl-1-(2-piperidinophenyl)-1-butylamine |
| 09/14/2011 | EP1809288B1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases |
| 09/14/2011 | EP1740535B1 Thio-substituted arylmethanesulfinyl derivatives |
| 09/14/2011 | EP1605752B1 Sulfonamides for the treatment of congestive heart failure, their compositions and uses. |
| 09/14/2011 | EP1257264B1 Estrogen receptor modulators |
| 09/14/2011 | CN1642551B Inhibitors of histone deacetylase |
| 09/14/2011 | CN102186845A S1p receptors modulators and their use thereof |
| 09/14/2011 | CN102186803A Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors |
| 09/14/2011 | CN102186800A 2,5-linked polyfluorenes for optoelectronic devices |
| 09/14/2011 | CN102180844A Gefitinib intermediate and preparation method of Gefitinib |
| 09/13/2011 | US8017771 Process for preparing acyclic HCV protease inhibitors |
| 09/13/2011 | US8017617 Amidine-containing compounds useful as muscarinic receptor antagonists |
| 09/13/2011 | CA2486869C Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 09/09/2011 | WO2011109355A1 Compounds for immunoproteasome inhibition |
| 09/09/2011 | WO2011109345A1 Isotopically enriched arylsulfonamide ccr3 antagonists |
| 09/09/2011 | WO2011108724A1 Prophylactic or therapeutic agent for diabetes or obesity |
| 09/09/2011 | WO2011108690A1 Alkylamine derivative |
| 09/09/2011 | WO2011107474A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 09/09/2011 | WO2010123960A3 Arylsulfonamide ccr3 antagonists |
| 09/09/2011 | WO2010123956A3 2,5-disubstituted arylsulfonamide ccr3 antagonists |
| 09/09/2011 | CA2791964A1 Isotopically enriched arylsulfonamide ccr3 antagonists |
| 09/09/2011 | CA2791651A1 Compounds for immunoproteasome inhibition |
| 09/09/2011 | CA2791431A1 Derivatives of aminoindanes, their preparation and their application in therapeutics |
| 09/09/2011 | CA2791174A1 Alkylamine derivative |
| 09/09/2011 | CA2733475A1 Morpholine derivatives as ashless tbn sources and lubricating oil compositions containing same |
| 09/08/2011 | US20110218207 Isotopically enriched arylsulfonamide ccr3 antagonists |
| 09/08/2011 | US20110218204 Pharmaceutically acceptable salts of novel betulinic acid derivatives |
| 09/08/2011 | US20110217720 Compositions and Kits Pertaining to Analyte Determination |
| 09/07/2011 | EP2363393A1 Compounds and compositions as hedgehog pathway modulators |
| 09/07/2011 | CN101565409B Piperazidine or homopiperazine oxalyl hydrazine class compound, preparation and use thereof |
| 09/07/2011 | CN101331122B Salts of modulators of PPAR and methods of treating metabolic disorders |
| 09/07/2011 | CN101198601B Methods and intermediates for the preparation of optionally radio-labeled imatinib |
| 09/06/2011 | US8013241 Ionic gel electrolyte, dye-sensitized photoelectric conversion device and solar cell |
| 09/06/2011 | US8013174 Photochromic spirodihydrophenanthropyrans |
| 09/06/2011 | US8012982 Modulators of HCV replication |
| 09/06/2011 | US8012962 Substituted thiomorpholine derivatives |